G Burmester
Overview
Explore the profile of G Burmester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alexander T, Burmester G
Z Rheumatol
. 2020 Jun;
79(5):417-418.
PMID: 32494983
No abstract available.
2.
Schulze-Koops H, Holle J, Moosig F, Specker C, Aries P, Burmester G, et al.
Z Rheumatol
. 2020 Apr;
79(4):385-388.
PMID: 32342184
In the current SARS-CoV-2 pandemic there are many questions regarding the safe treatment of patients with inflammatory rheumatic diseases. Many of these questions cannot yet be answered on an evidence-based...
3.
Fiehn C, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, et al.
Z Rheumatol
. 2018 Jul;
77(Suppl 2):35-53.
PMID: 29968101
Background: Medication-based strategies to treat rheumatoid arthritis are crucial in terms of outcome. They aim at preventing joint destruction, loss of function and disability by early and consistent inhibition of...
4.
Massenkeil G, Alexander T, Rosen O, Dorken B, Burmester G, Radbruch A, et al.
Rheumatol Int
. 2016 Aug;
36(11):1563-1568.
PMID: 27522225
Issues of fertility and pregnancy require special attention in the long-term care of patients with autoimmune diseases (AD), who are candidates for haematopoietic stem cell transplantation (HSCT). In this single-centre...
5.
Baraliakos X, Heldmann F, Van den Bosch F, Burmester G, Gaston H, van der Horst-Bruinsma I, et al.
RMD Open
. 2016 Aug;
2(2):e000272.
PMID: 27493791
Objective: To analyse the treatment outcome of patients with ankylosing spondylitis (AS) in the European AS infliximab cohort (EASIC) study after a total period of 8 years with specific focus...
6.
Braun J, Krause A, Aringer M, Burmester G, Bessler F, Engel J, et al.
Z Rheumatol
. 2016 May;
75(4):416-28.
PMID: 27138788
In a joint initiative by the boards of the German Society for Rheumatology (DGRh) and the Association of Rheumatology Clinics (VRA) the European "standards of care" for rheumatoid arthritis, recently...
7.
Gossec L, Smolen J, Ramiro S, de Wit M, Cutolo M, Dougados M, et al.
Ann Rheum Dis
. 2015 Dec;
75(3):499-510.
PMID: 26644232
Background: Since the publication of the European League Against Rheumatism recommendations for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence and new therapeutic agents have emerged. The...
8.
Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, et al.
Lupus
. 2013 Sep;
22(11):1142-9.
PMID: 24057058
Objective: The objective of this article is to evaluate the safety and clinical outcome of rituximab treatment in systemic lupus erythematosus (SLE) patients refractory to standard of care therapy in...
9.
Kruger K, Wollenhaupt J, Albrecht K, Alten R, Backhaus M, Baerwald C, et al.
Z Rheumatol
. 2012 Aug;
71(7):592-603.
PMID: 22930110
Following the EULAR recommendations published in 2010 German guidelines for the medical treatment of rheumatoid arthritis were developed based on an update of the systematic literature search and expert consensus....
10.
Kalden J, Burkhardt H, Buss B, Donhauser-Gruber U, Erstling U, Gromnica-Ihle E, et al.
Z Rheumatol
. 2011 Oct;
70(8):641-50.
PMID: 21979315
New therapeutic principles and considerable diagnostic advances have made it possible to define different rheumatic diseases and especially rheumatoid arthritis (RA) at an early stage and by starting an early...